Orthogon Therapeutics
PrivateLast Round
Follow-on Offering
Apr 17, 2026
Total Funding Raised
$23.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Orthogon Therapeutics operates in Healthcare & Life Sciences and is based in Canton, Massachusetts. Its latest recorded funding round was a Follow-on Offering round in April 2026.
Orthogon Therapeutics is a biotechnology company that develops small molecule antiviral drugs for polyomavirus infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orthogon Therapeutics Comparables
Compare Orthogon Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hybridize Therapeutics | 81% | |
| Ipsen | 79% | |
| Asahi Kasei | 74% |
For institutional investors. Book with your work email.
Orthogon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 17, 2026 | ||||
| VC Round | Dec 10, 2024 | ||||
| VC Round | Jul 24, 2023 | ||||
| Follow-on Offering | Nov 8, 2021 | ||||
| Series A | Mar 8, 2018 |
For institutional investors. Book with your work email.
Orthogon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Healthcare Angels | Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 235% MoM, from 651 to 2.2K.
- Apr 17, 2026
$11M raised in follow-on offering.
For institutional investors. Book with your work email.
Orthogon Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orthogon Therapeutics's valuation, stock price, and market status.
Is Orthogon Therapeutics a public or private company?
Orthogon Therapeutics is a private company.
What is the current stock price of Orthogon Therapeutics?
Orthogon Therapeutics is a private company, so its shares have no public market price. Caplight tracks Orthogon Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orthogon Therapeutics worth (valuation)?
Valuation information for Orthogon Therapeutics is not publicly available.
Can I buy Orthogon Therapeutics stock?
Orthogon Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orthogon Therapeutics's last funding round?
Orthogon Therapeutics's most recent funding round was Follow-on Offering on April 17, 2026.
Who are the main investors in Orthogon Therapeutics?
Key investors in Orthogon Therapeutics include Healthcare Angels.
Will Orthogon Therapeutics IPO soon?
No public IPO plans have been announced for Orthogon Therapeutics.
How can I track Orthogon Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Orthogon Therapeutics's shares on secondary markets.